Loading insider details...
Latest Form 4 (Jul 10, 2026): Sale of 200,000 TSHA shares, $1.25M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 10, 2026 | Taysha Gene Therapies, Inc. (TSHA) | Sale | 200,000 | $1.25M |
| Jun 11, 2026 | Solid Biosciences Inc. (SLDB) | Grant/Award | 77,500 | n/a |
| Apr 13, 2026 | Taysha Gene Therapies, Inc. (TSHA) | Exercise/Conversion | 19,021 | $32.5K |
| Jan 27, 2026 | Taysha Gene Therapies, Inc. (TSHA) | Sale | 89,132 | $423.4K |
| Jan 14, 2026 | Taysha Gene Therapies, Inc. (TSHA) | Exercise/Conversion | 111,324 | $77.8K |
| Dec 2, 2025 | Taysha Gene Therapies, Inc. (TSHA) | Exercise/Conversion | 70,172 | $49.0K |
| Sep 12, 2025 | Taysha Gene Therapies, Inc. (TSHA) | Exercise/Conversion | 41,150 | $28.8K |
| Aug 22, 2025 | Taysha Gene Therapies, Inc. (TSHA) | Sale | 57,054 | $162.6K |
| Jun 13, 2025 | Solid Biosciences Inc. (SLDB) | Grant/Award | 77,500 | n/a |
| Jan 3, 2025 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 324,500 | n/a |